Skip to content

BodyReal prosthetics

Active
Private limited companyfounded 2020active for 6 yearsRozendal 49, 8000 Brugge, BelgiumKBO/BCE: BE 0744.552.994
Summary

BodyReal prosthetics has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,167 and a net result of €4,167. Equity is shrinking by about 3.1% per year across the filed financial years. Its solvency ranks better than 28% of 22,679 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741
1 site
Size
≈ €89,000turnover 2025, estimated
Equity
€7,167
Profit
€4,167
Turnover estimated from the gross margin
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Structure
2025 accounts filed 24 days late2 deeds in the Belgian Official Gazette
Why 70raises riskEquity €7,167 (8.7% of total assets)Founded in 2020lowers riskLiquidity: current ratio 1.09, cash €66,064Size: total assets €82,229Show the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 36% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 34-59
equity 8.7% of total assets
Liquidity 50-37
short-term debt 90.7% · cash 80.3%
Profitability 75-25
return on assets 5.1%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,268 companies, NACE 47, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.5%▲ +0.1 percentage points vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.6%▲ +0.1 percentage points vs 06-2025 08-2025: 1.0%▲ +0.4 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.9 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.6%▲ +0.3 percentage points vs 08-2026 10-2026: 0.6%● unchanged vs 09-2026
Credit of up to €500 on 30-day terms is acceptable
Liquidity tight (current ratio 1.09, compared with 3.09 in 2024, below the usual 1.5; short-term debt: 90.7% and cash: 80.3% of total assets), and 91.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 26% on solvency, 52% on liquidity, 61% on profitability and 6% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 1.09, cash €66,064
NBB · annual accounts
raises risk · Equity €7,167 (8.7% of total assets)
NBB · annual accounts
raises risk · Founded in 2020
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €82,229
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 6 filings
Deviation from the deadline
2025
24 days late
2024
7 days late
2023
36 days early
2022
40 days early
2021
11 days early
2020
40 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 16 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Back to profitnet €27,477

Key points

  • Caution: Equity fell in 2025from €63,977 to €7,167 ▼ 88.8% View
  • Total assets 20256 financial years filed €82,229 View
  • Active since 2020founded 28-02-2020 6 years View

By topic

Financials

Financial year
2025
Total assets
€82,229
Profit
€4,167
Solvency
8.7%
Total assets▼ 12.0%
Net result
20202025
Go to Financials

Timeline

Events
10
Since
2021
Next accounts
by 31-07-2027
  1. 25-06-2024Annual accounts filed
  2. 31-12-2023Weakest financial year
  3. 31-12-2023Liquidity more than doubled
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
28-02-2020
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about BodyReal prosthetics

What is the company number of BodyReal prosthetics?
0744.552.994. In Belgium the VAT number is the company number with BE in front: BE 0744.552.994.
Where is BodyReal prosthetics based?
The registered office is at Rozendal 49, 8000 Brugge.Company details
What does BodyReal prosthetics do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of BodyReal prosthetics?
Private limited company (BV).
When was BodyReal prosthetics founded?
On 28-02-2020.
Is BodyReal prosthetics still active?
Yes, BodyReal prosthetics is an active enterprise in the KBO register.
What is the turnover of BodyReal prosthetics?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is BodyReal prosthetics profitable?
In financial year 2025, BodyReal prosthetics made a profit of €4,167.
Where can I find the annual accounts of BodyReal prosthetics?
BodyReal prosthetics filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BodyReal prosthetics due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to BodyReal prosthetics

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.